This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PETscans.
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, the average number of PETscans per fixed PET site (versus mobile PET) increased 6.7%
F-18 florbetaben PETscans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PET imaging in clinical settings,” the group wrote.
Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PETscan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PETscans will now be made by local Medicare Administrative Contractors (MACs).
In a study published April 17 in Clinical NuclearMedicine , the group at Brigham tested a new TSPO radiotracer they developed for visualizing such activity called F-18 PBR06. The researchers performed F-18 PBR06 PETscans on 22 patients with MS and eight healthy controls. Image courtesy of Clinical NuclearMedicine.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PETscans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
An AI algorithm designed for brain PET imaging found a glioblastoma in a patient that had gone undetected by physicians, according to a case reported February 15 in the Journal of NuclearMedicine. Baseline scan (A), segmentation results (B), and follow-up scan (C) from patient with molecular glioblastoma.
A PET radiotracer for diagnosing Alzheimer’s disease may also be used to measure vascular brain changes in patients during PET/MRI scans, according to a study published December 7 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
TORONTO -- AuntMinnie.com spoke with prostate cancer imaging expert Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, at the Society of NuclearMedicine and Molecular Imaging annual meeting about new developments in PET/CT imaging in patients on Lu-177 PSMA-617 therapy. last year for Alzheimer's disease.
PET imaging shows different brain activity in people taking methadone or buprenorphine for opioid use disorder (OUD), according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging annual meeting. They tracked serum levels of methadone or buprenorphine for the OUD subjects.
Two experts review SNMMI (Society of NuclearMedicine and Molecular Imaging) guidelines for use of PSMA PETscans in prostate cancer detection, as well as awareness about this new modality within the patient community.
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. “In
PET imaging using a newly developed radiotracer has identified different patterns of brain tau pathology over time in early-onset versus late-onset Alzheimer’s disease patients, according to a study published February 1 in the Journal of NuclearMedicine. in 15 patients with negative amyloid PETscans; 1.18 in
A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PETscans, according to a study published October 13 in Medical Hypotheses. “We A) PETscan of a healthy subject. (B) B) PETscan of a long COVID patient.
“The results obtained with a portable PET scanner in this comparison in humans require follow-up but lend confidence to the feasibility of more flexible and portable brain imaging with PET,” noted first author Elizabeth Bartlett, PhD, of the New York State Psychiatric Institute. A link to the full study can be found here.
The findings were published in Clinical NuclearMedicine. The newly published study involved performing PETscans on 22 people with MS and eight healthy controls. Those being treated with low-efficacy treatments had more abnormalities on their PETscans, suggesting more microglial cell activation.
Dynamic PETscans acquired in half the time of normal scans appear clinically feasible for patients with lung lesions, according to nuclearmedicine researchers in Shenzhen, China. The article was published March 5 in EJNMMI Physics.
F-18 fluoroestradiol (FES)-PETscans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Patients with less tau pathology on PETscans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
Scans processed with the algorithm can also provide additional details by using an overlay of an MRI or CT image of the same region, the company said. More than 500,000 PETscans are performed per year in India, with demand for nuclearmedicine growing, Claritas noted.
Gallium-68 (Ga-68) fibroblast activation protein inhibitor (FAPI) PET/CT is a promising new method for imaging gastric cancer, according to a study published January 16 in the Journal of Cancer Research and Clinical Oncology.
An international survey of treatment centers has revealed significant differences in several aspects of Lu-177 PSMA-617 prostate cancer therapy, including patient imaging protocols, according to a study published January 18 in the Journal of NuclearMedicine. In addition, different PET radiotracers are used.
A new artificial intelligence tool provides a fully automated, easy-to-use and objective way to detect and evaluate brain tumors, according to new research published in the October issue of the Journal of NuclearMedicine.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PETscans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PETscans predict patient response to Pluvicto.
Researchers have found biomarkers that enable doctors to reliably distinguish the two conditions—albeit only with data from a particular imaging technique called positron emission tomography (PET).
A new PETscan has shown promise in reliably detecting benign tumors in the pancreas that cannot be detected by various imaging techniques such as CT, MRI, and PETscans.
30, 2025 Earlier this month, the Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,
Reimbursement barriers Unfortunately, until recently, there were significant barriers to receiving amyloid PET imaging in some regions. Centers for Medicare and Medicaid Services (CMS), for example, did not cover amyloid PETscans outside of clinical trials for Medicare beneficiaries and only covered one scan per patient’s lifetime.
milla1cf Fri, 02/09/2024 - 09:17 February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of NuclearMedicine.
Computerized tomography (or a CT scan) combines images from different angles to create cross-section pictures of the body with more information than typical X-ray technology. Positron Emission Tomography (a PETscan) uses nuclearmedicine to detect metabolic signals emitted by cancer cells.
mtaschetta-millane Sat, 06/24/2023 - 15:00 June 24, 2023 — A newly developed technology called “augmented whole-body scanning via magnifying PET” ( AWSM-PET ) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging.
Flavio Forrer , MD, PhD, Chairman of NuclearMedicine in the Division of Radiology and NuclearMedicine at Kantonsspital St. v] Up to 53% reduction of PETscan time on Omni Legend 32 cm compared to Discovery MI 25 cm, as demonstrated in phantom testing. [vi] Gallen in Switzerland [vii]. ix Mehranian, A.,
For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market. Fruhwirth, G.
Brain Tumor Spotted on PET Imaging An AI algorithm named “JuST_BrainPET” identified a glioblastoma in a patient that had been missed by physicians. This finding, reported in the Journal of NuclearMedicine, underscores the potential of AI-based decision support in diagnostic and treatment planning.
PETScan: These scans create 3D images that offer greater insight into whether a thickened pleura or peritoneum is malignant mesothelioma or a benign condition. This nuclearmedicinescan uses a radioactive substance to further determine if the cancer has spread to the lymph nodes and other parts of the body.
PACS works as a host that integrates the radiological images acquired from different radiological imaging modalities (X-Ray, Ultrasound, CT, MRI , PETScan, NuclearMedicine, etc…) with a network of information system (RIS and or HIS), EMR, different work stations and image storage/archival system.
Theranostics pairs diagnostic biomarkers that can be visualized on nuclearmedicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclearmedicine technologist, and radiation safety team are all present to administer an infusion.
Radiopharmaceuticals in diagnostics provide critical insights into disease processes, improving accuracy, patient care, and treatment outcomes significantly. The post The Transformative Power of Radiopharmaceuticals in Diagnostics appeared first on Open MedScience.
Theranostics pairs diagnostic biomarkers that can be visualized on nuclearmedicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclearmedicine technologist, and radiation safety team are all present to administer an infusion.
Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically. The post Breakthroughs in Positron Emission Tomography Imaging appeared first on Open MedScience.
Several presenters at the Society for NuclearMedicine and Molecular Imaging's (SNMMI) 2024 meeting in Toronto shared new findings in women's studies. Both groups would undergo standard of care imaging, or CT and bone scan, or FDG PET/CT, or FES PET/CT. Women's theranostics appears to already be on the horizon.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content